ST
A Collaborative Practice
UV
5th Edition
TEST BANK
IA
_A
Terry Mahan Buttaro
PP
JoAnn Trybulski
Patricia Polgar-Bailey
Joanne Sandberg-Cook
────────────────────────────────────────────────────
RO
Comprehensive Test Bank for Instructors
and Students
VE
© Terry Mahan Buttaro, JoAnn Trybulski, Patricia Polgar-Bailey & Joanne
Sandberg-Cook. All rights reserved. Reproduction or distribution without
permission is prohibited.
D?
(All Chapters Covered)
, Complete Test Bank – Primary Care: A Collaborative Practice, 5th Edition
Terry Mahan Buttaro • JoAnn Trybulski • Patricia Polgar-Bailey • Joanne Sandberg-Cook
Foundations of Collaborative Primary Care
Chapter 1: The Changing Landscape of Collaborative Practice
ST
Chapter 2: Transitional Care
Chapter 3: Translating Research into Clinical Practice
Chapter 4: The Patient, the Provider, and Primary Care
Chapter 5: Population-Based Care for Primary Care Providers
Chapter 6: Health Literacy, Health Care Disparities, and Culturally Responsive Primary
UV
Care
Chapter 7: Genetic Considerations in Primary Care
Chapter 8: Risk Management
Special Populations and Preventive Care
Chapter 9: Adolescent Issues
IA
Chapter 10: LGBTQ Patient Care
Chapter 11: Pregnancy and Prenatal Care
Chapter 12: Lactation Guidance
Chapter 13: Aging and Common Geriatric Syndromes
_A
Chapters 14–23: Palliative Care, Lifestyle Medicine, Occupational Health, Immunizations,
Travel Medicine, Disaster Preparedness
Emergency and Acute Care
Chapters 24–37: Acute and Emergency Conditions (Acute Bronchospasm through Thermal
PP
Injuries)
Dermatology
Chapter 38: Examination of the Skin and Diagnostic Approach
Chapters 39–69: Dermatologic Disorders and Wound Management
RO
Ophthalmology, Otolaryngology, and Oral Health
Chapters 70–101: Eye, Ear, Nose, Throat, and Oral Conditions
Pulmonary Disorders
VE
Chapter 102: Acute Bronchitis
Chapters 103–115: Chronic and Systemic Pulmonary Disorders (through Sarcoidosis)
Cardiovascular Disorders
Chapter 116: Cardiac Diagnostic Testing
D?
Chapters 117–126: Cardiac Conditions, Murmurs, and Valvular Disease
Gastrointestinal Disorders
Chapter 127: Abdominal Pain and Infections
Chapters 128–144: Gastrointestinal and Hepatobiliary Disorders
Genitourinary and Men’s Health
Chapters 145–154: Genitourinary Disorders and Men’s Health
, Women’s Health
Chapter 155: Amenorrhea
Chapters 156–170: Gynecologic and Reproductive Disorders
Musculoskeletal and Orthopedic Disorders
Chapters 171–187: Musculoskeletal Conditions and Injuries
ST
Neurologic Disorders
Chapter 188: Neuropsychological Evaluation
Chapters 189–203: Neurologic Disorders and Intracranial Conditions
Endocrine and Metabolic Disorders
UV
Chapters 204–214: Endocrine and Metabolic Conditions
Rheumatologic and Autoimmune Disorders
Chapters 215–220: Autoimmune and Rheumatologic Conditions
Environmental, Nutritional, and Specialty Topics
IA
Chapter 221: Barotrauma and Diving Injuries
Chapters 222–228: Environmental Exposure and Nutritional Disorders
Infectious Diseases
_A
Chapter 229: Emerging and Reemerging Infectious Diseases
Chapters 230–236: Viral, Vector-Borne, and Systemic Infections
Hematology and Oncology
Chapter 237: Anemia
PP
Chapters 238–246: Hematologic and Oncologic Disorders
Mental Health
Chapter 247: Anxiety Disorders
RO
Chapter 248: Mood Disorders
Chapter 249: Substance Use Disorders
Chapter 250: Other Mental Health Disorders
VE
D?
, Buttaro: Primary Care, A Collaborative Practice, 5th Ed.
Chapter 4: The Patient, the Provider, and Primary Care: An IntegratedPerspective
Test Bank
Multiple Choice
ST
1. A patient takes glucosaminechondroitin to help control
UV
osteoarthritis pain. Whichmedications, taken in conjunction with this
medication, are of concern?
a. Anticholinergic drugs
IA
b. Beta blocker medications
c. Blood-thinning agents
_A
d. Narcotic analgesics
ANS: C
Glucosamine chondroitin can prolong bleeding if taken with other blood-thinning agents. It does
PP
not have anticholinergic effects, cardiac effects or analgesic effects. REF: Alternative Therapies
for Common Chronic Conditions/Joint Pain
RO
2. The provider learns that a patient is taking herbal supplements for a variety of reasons.
Whatis an important point to discuss with this patient about taking suchsupplements?
VE
a. Because they are not FDA approved, they are not safe
b. Dietary supplements are safer than most prescription medications
c. Many supplements lack clear clinical evidence of efficacy
D?
d. Supplements should not be taken with prescription medicationsANS:
C
Med C File © 2022